chevron_leftBack
As of 19 June 2026, DT&CRO CO., Ltd. has a market cap of $29.5M USD, ranking #34382 globally and #2129 in South Korea.
It ranks #7840 in the Industrials sector, and #959 in the Specialty Business Services industry.
Key Stats
Market Cap
$29.5MUSD
45.0B KRW
Enterprise Value
$53.34MUSD
80.52B KRW
Revenue (TTM)
$31.3MUSD
47.75B KRW
EBITDA (TTM)
$322.85KUSD
487.3M KRW
Net Income (TTM)
-$1.82MUSD
-2.78B KRW
EBITDA Margin
1%
Profit Margin
-5.8%
PS Ratio
0.9
PB Ratio
1.8
EV/EBITDA
165.2
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
Founded
2017
Website
dtncro.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.3% | 2.7% | 8.4% | 39% | 21% | -37% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
383930
주식회사 디티앤씨알오
ISIN: KR7383930005
Shares Out.:
Shares Outstanding:
12.784M1
Shares Float:
8.854M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3,520 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About DT&CRO CO., Ltd.
DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional food, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin-si, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 352820
|
$7.12B
24K%
10.85T KRW
|
-
|
|
KRX: 377300
|
$5.02B
17K%
7.65T KRW
|
169.0
|
|
KRX: 0009K0
|
$2.07B
7K%
3.15T KRW
|
627.7
|
|
KRX: 012750
|
$1.92B
6K%
2.93T KRW
|
16.4
|
|
KRX: 131970
|
$1.66B
6K%
2.54T KRW
|
69.0
|
|
KRX: 174900
|
$658.38M
2K%
1.0T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: SHOP
|
$158.14B
536K%
|
129.8
|
|
STO: VSURE
|
$132.46B
449K%
114.8B EUR
|
-
|
|
NASDAQ: CTAS
|
$69.6B
236K%
|
36.8
|
|
LSE: REL
|
$63.49B
215K%
47.6B GBP
|
23.9
|
|
NASDAQ: PYPL
|
$45.83B
155K%
|
9.4
|
|
|
T
NEO: TRI
|
$41.8B
142K%
56.91B CAD
|
-
|
chevron_leftBack